01 July 2009
The world's top 50 pharmaceutical companies accounted for prescription drug sales of $558 billion (413 billion euro) in 2008.
 |
01 June 2009
Murray Aitken, senior vice president, Healthcare Insight, at IMS Health explains why IMS Health has lowered its predicted growth for the 2009 global pharmaceutical market from a previous forecast in October 2008.
|
01 April 2009
By:Jim Miller
Despite the market downturn and financial meltdown, private equity investors are lining up for pharmaceutical services businesses.
|
01 April 2009
By:Michael Harris
Pharmaceutical Technology Europe (PTE) talks to Michael Harris, Managing Director UK and Ireland Sigma Aldrich and Vice President SAFC, about the company's strategies to overcome industry pressures and accommodate industry trends.
|
01 February 2009
By:Julian Upton
Nycomed?s long-standing CEO Håkan Björklund tells Julian Upton how the company is looking to new products and new territories to combat the patent expiry of its top seller.
|
01 February 2009
The opportunities Singapore offers to pharma and biotech companies.
|
01 February 2009
By:Jacky Law
Pfizer is no normal company. As recently as 2007 it was still the industry's largest player with $47.5 billion (36.8 billion euro) coming in from pharma sales alone.
|
01 January 2009
By:Paul Gardiner, Andrea Sobrio
Paul Gardiner and Andrea Sobrio explain why most companies need 'organizational polygamy' to maximize profit and best serve their customers.
|
01 January 2009
By:Brian D. Smith
Conflict between departments costs money, wastes time and hinders strategy implementation. But we can reduce it and manage it if we understand it, says Dr Brian D. Smith.
|
| 
